SCHEMBL15096860

SCHEMBL15096860

COc1ccc(C(Br)C(=O)c2ccc(-c3ccccc3)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
CYP3A4 P08684 2/20 0.59
CYP1A2 P05177 1/20 0.55
RAB9A P51151 5/20 0.51
POLB P06746 5/20 0.51
NPC1 O15118 4/20 0.51
KMT2A Q03164 4/20 0.51
MAPT P10636 3/20 0.51
MEN1 O00255 2/20 0.51
CES2 O00748 1/20 0.50
CES1 P23141 1/20 0.50
CTDSP1 Q9GZU7 3/20 0.48
NPSR1 Q6W5P4 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ADORA3 P0DMS8 1/20 0.47
PAX8 Q06710 1/20 0.47
MITF O75030 1/20 0.46
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15092882 1.00 ALDH1A1 (0.59) ALDH1A1CYP3A4CYP1A2RAB9APOLB
SCHEMBL6201289 0.91 ALDH1A1 (0.61) ALDH1A1CYP3A4CYP1A2RAB9APOLB
SCHEMBL7017619 0.91 ALDH1A1 (0.57) ALDH1A1CYP3A4CYP1A2RAB9APOLB
SCHEMBL3089210 0.89 ALDH1A1 (0.62) ALDH1A1CYP1A2RAB9APOLBNPC1
SCHEMBL2150940 0.83 ALDH1A1 (0.55) ALDH1A1CYP1A2RAB9APOLBNPC1
SCHEMBL3105019 0.83 ALDH1A1 (0.55) ALDH1A1CYP1A2RAB9APOLBNPC1
SCHEMBL6208904 0.82 RAB9A (0.58) ALDH1A1RAB9APOLBNPC1MAPT
SCHEMBL6210392 0.82 RAB9A (0.58) ALDH1A1RAB9APOLBNPC1MAPT
SCHEMBL3092612 0.82 HPGD (0.60) ALDH1A1CYP1A2RAB9APOLBNPC1
SCHEMBL3092509 0.82 HPGD (0.60) ALDH1A1CYP1A2RAB9APOLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8969573-B2 Compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-03-03 US disclosed
US-8969573-B2 Compounds for the inhibition of cellular proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2015-03-03 US disclosed
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-07-11 US disclosed
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178505-A1 Compounds for the Inhibition of Cellular Proliferation MKI67, EIF2AK2, CDK2 ALDH1A1 3428/4885CYP3A4 4839/4885CYP1A2 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.